SkinHealth Systems Inc.
Every calculator, already run for SKIN
Open the full toolkit →You have the numbers on SKIN. Get the argument.
A written report on which of these readings actually decide the outcome for SkinHealth Systems Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
9 analysts covering SKINAnalyst Price Target Disagreement for SkinHealth Systems Inc.
Wall Street's bull case implies +194% from the current price; the bear case implies +4%. A 190% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
About SkinHealth Systems Inc.
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and na…
SKIN — frequently asked
Is SKIN a buy right now?
Wall Street's consensus rating on SkinHealth Systems Inc. is Hold across 9 analysts, with a mean price target of $1.26 (+85% vs. the current $0.68). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is SKIN overvalued?
SKIN trades at — trailing earnings, against a DCF fair value of $9 per share. The current price implies -10% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is SKIN's next earnings date?
SkinHealth Systems Inc. is next scheduled to report earnings around Nov 5, 2026. A full SKIN research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for SkinHealth Systems Inc.?
Analysts covering SkinHealth Systems Inc. (SKIN) range from a bear-case target of $0.71 to a bull-case high of $2.00, with a mean consensus target of $1.26 across 6 analysts. The spread of $1.29 (190% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare SkinHealth Systems Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For SkinHealth Systems Inc.
Start with the evergreen guides that matter most for Consumer Defensive, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full SKIN research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on SkinHealth Systems Inc., in minutes. 3 free reports included with every account — no credit card required.